{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:20:16Z","timestamp":1794108016897,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["GC-201711\\u20132014197"],"award-info":[{"award-number":["GC-201711\\u20132014197"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG057684"],"award-info":[{"award-number":["R01AG057684"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106316","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:10:26Z","timestamp":1781827826000},"page":"106316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-649X","authenticated-orcid":false,"given":"Hussein N.","family":"Yassine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Ghasem","family":"Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6333-5101","authenticated-orcid":false,"given":"Marlene","family":"Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella C.","family":"Arrelanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Dikeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9112-2101","authenticated-orcid":false,"given":"Jackson","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-3288","authenticated-orcid":false,"given":"Bilal","family":"Kerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2590-2900","authenticated-orcid":false,"given":"Marlon V.","family":"Duro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Asante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina M.","family":"D'Orazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6439-4243","authenticated-orcid":false,"given":"Meredith N.","family":"Braskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106316_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(00)00017-5","article-title":"The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina","volume":"40","author":"Lauritzen","year":"2001","journal-title":"Prog Lipid Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106316_bib2","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1096\/fj.201901890RR","article-title":"Impairment of DHA synthesis alters the expression of neuronal plasticity markers and the brain inflammatory status in mice","volume":"34","author":"Talamonti","year":"2020","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106316_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4062\/biomolther.2012.20.2.152","article-title":"Effects of docosahexaenoic acid on neurotransmission","volume":"20","author":"Tanaka","year":"2012","journal-title":"Biomol Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106316_bib4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0306-4522(94)90515-0","article-title":"Arachidonic acid: toxic and trophic effects on cultured hippocampal neurons","volume":"63","author":"Okuda","year":"1994","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106316_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","article-title":"ApoE4: an emerging therapeutic target for Alzheimer's disease","volume":"17","author":"Safieh","year":"2019","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106316_bib6","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamaneurol.2016.1924","article-title":"Association of serum docosahexaenoic acid with cerebral amyloidosis","volume":"73","author":"Yassine","year":"2016","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106316_bib7","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2026.106316_bib8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"\u03c9-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study: a randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106316_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2010.09.001","article-title":"Apolipoprotein E: from lipid transport to neurobiology","volume":"50","author":"Hauser","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.ebiom.2026.106316_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","volume":"16","author":"Genin","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ebiom.2026.106316_bib11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","article-title":"APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes","volume":"611","author":"Blanchard","year":"2022","journal-title":"Nature"},{"issue":"s1","key":"10.1016\/j.ebiom.2026.106316_bib12","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.3233\/JAD-231467","article-title":"Designing newer Omega-3 supplementation trials for cognitive outcomes: a systematic review guided analysis","volume":"101","author":"Yassine","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106316_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-017-0250-1","article-title":"DHA brain uptake and APOE4 status: a PET study with [1-11 C]-DHA","volume":"9","author":"Yassine","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106316_bib14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.14283\/jpad.2023.77","article-title":"Baseline findings of PreventE4: a double-blind placebo controlled clinical trial testing high dose DHA in APOE4 carriers before the onset of dementia","volume":"10","author":"Yassine","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2026.106316_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102883","article-title":"Brain delivery of supplemental docosahexaenoic acid (DHA): a randomized placebo-controlled clinical trial","volume":"59","author":"Arellanes","year":"2020","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106316_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13195-022-01084-7","article-title":"Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia","volume":"14","author":"Ebright","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106316_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity","volume":"20","author":"Randolph","year":"1998","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106316_bib18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/jnc.12640","article-title":"Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2","volume":"129","author":"Vandal","year":"2014","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106316_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-022-00549-5","article-title":"Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4","volume":"17","author":"Wang","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106316_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.tem.2024.03.003","article-title":"Effects of APOE4 on omega-3 brain metabolism across the lifespan","volume":"35","author":"Ebright","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106316_bib21","article-title":"Marine n-3 fatty acids and cognitive change among older adults in the VITAL randomized trial","volume":"8","author":"Kang","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106316_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1474-4422(17)30332-0","article-title":"24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial","volume":"16","author":"Soininen","year":"2017","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106316_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","article-title":"The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress","volume":"9","author":"Kivipelto","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106316_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jamainternmed.2023.6279","article-title":"Effect of personalized risk-reduction strategies on cognition and dementia risk profile among older adults: the SMARRT randomized clinical trial","volume":"184","author":"Yaffe","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106316_bib25","first-page":"116","article-title":"Can the gut microbiome inform the effects of omega-3 fatty acid supplementation trials on cognition?","volume":"27","author":"Kerman","year":"2024","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106316_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/alz.12172","article-title":"36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease","volume":"17","author":"Soininen","year":"2021","journal-title":"Alzheimers Dement"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:13:08Z","timestamp":1783498388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S2352396426001982"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106316","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106316"}}